1.Farrington, CP. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993; 22: 742–746.
2.Valenciano, M, et al. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28: 7381–7388.
3.Kelly, H, et al. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009; 4: e5079.
4.Skowronski, DM, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25: 2842–2851.
5.Hardelid, P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009–2010. Eurosurveillance 2011; 16: pii=19763.
6.Wichmann, O, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009–2010. Eurosurveillance 2010; 15: pii=19561.
7.Skowronski, DM, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. British Medical Journal 2011; 342: c7297.
8.Savulescu, C, et al. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network – pilot case-control studies using different control groups, 2008–2009 season, Spain. Vaccine 2010; 28: 2903–2907.
9.Pebody, R, et al. Effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Eurosurveillance 2011; 16: pii=19791.
10.Brooks-Pollock, E, et al. Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infectious Diseases 2011; 11: 68.
11.Tilston, N, et al. Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 2010; 10: 650.
12.Friesma, I, et al. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in the Netherlands. Vaccine 2009; 27: 6353–6357.
13.McNutt, LA, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 2003; 157: 940–943
14.Zou, G. A modified Poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 2004; 159: 702–706.
15.Zhang, J, Yu, KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. Journal of the American Medical Association 1998; 280: 1690–1691.
16.Ihaka, R, Gentleman, R. R: A language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996; 5: 299–314.
17.StataCorp. Stata statistical software: release 11. College Station, TX: StataCorp LP, 2009.
19.Bridges, CB, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults. Journal of the American Medical Association 2000; 284: 1655–1663.
20.Kissling, E, et al. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Eurosurveillance 2011; 16: pii=19818.
21.Savulescu, C, et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Eurosurveillance 2011; 16: pii=19820.